Literature DB >> 30599095

Oral tolerance:Recent advances on mechanisms and potential applications.

Thaniya Sricharunrat1, Pornpan Pumirat2, Pornsawan Leaungwutiwong2.   

Abstract

Oral tolerance is a type of immune hypo-responsiveness induced by oral administration of food or harmless gastrointestinal antigens. It is evident that the induction of oral tolerance can protect our body from enteric problems, such as food allergies and colitis caused by autoimmunity. Here we review the immunological mechanisms of oral tolerance, the role of T cell cytokines in generating tolerance and the impact of Peyer's patches and mesenteric lymph nodes, and discuss the part played by commensal microflora in the regulation and maintenance of the intestinal barrier. The potential clinical applications of oral tolerance in human disease therapy are also included in this review. Understanding the mechanisms of oral tolerance may lead to the development of alternative strategies for preventing or suppressing the symptoms of autoimmune diseases and allergies.

Entities:  

Mesh:

Year:  2018        PMID: 30599095     DOI: 10.12932/AP0848

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  6 in total

1.  Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model.

Authors:  Meng Tang; Rahat Ullah; Junaid Wazir; Farhan Ullah Khan; Awais Ullah Ihsan; Xingxing Cui; Wenlu Wang; Min Hu; Yuqian Liu; Xiaohui Zhou
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

Review 2.  Age-related changes in ocular mucosal tolerance: Lessons learned from gut and respiratory tract immunity.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Immunology       Date:  2021-05-02       Impact factor: 7.215

Review 3.  Type 1 diabetes mellitus and its oral tolerance therapy.

Authors:  Rui-Feng Mao; Ying-Ying Chen; Ji Zhang; Xin Chang; Ye-Fu Wang
Journal:  World J Diabetes       Date:  2020-10-15

4.  Oral delivery of the intracellular domain of the insulinoma-associated protein 2 (IA-2ic) by bacterium-like particles (BLPs) prevents type 1 diabetes mellitus in NOD mice.

Authors:  Ruifeng Mao; Menglan Yang; Rui Yang; Yingying Chen; Enjie Diao; Tong Zhang; Dengchao Li; Xin Chang; Zhenjing Chi; Yefu Wang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 5.  Leukoplakia and Immunology: New Chemoprevention Landscapes?

Authors:  Roberto Grigolato; Maria Eleonora Bizzoca; Luca Calabrese; Stefania Leuci; Michele Davide Mignogna; Lorenzo Lo Muzio
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

6.  Oral Tolerance Induction by Bothrops jararaca Venom in a Murine Model and Cross-Reactivity with Toxins of Other Snake Venoms.

Authors:  Lilian Rumi Tsuruta; Ana Maria Moro; Denise V Tambourgi; Osvaldo Augusto Sant'Anna
Journal:  Toxins (Basel)       Date:  2021-12-03       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.